Cristian Tornador Antolín

CEO and co-founder of BG, PhD in Biomedicine.

Dr. Tornador has a doctoral degree in Biomedicine. He is specialized in the analysis of genomic variations by means of new sequencing technologies. His participation and coordination in numerous international and clinical research projects have contributed to broaden his knowledge of being in command, managing and planning projects involving hospitals and research centers.


Mayka Sánchez Fernández

Promoter and co-founder of BG, PhD in Genetics.

Dr. Sanchez has a doctoral degree in Genetics. She has more than 20 years of experience working in basic and translational research on iron metabolism diseases. Dr. Sanchez worked for 8 years at the prestigious European Molecular Biology Laboratory (EMBL) at Heidelberg, Germany. She teaches genetics and is group leader at the Department of Basic Sciences (Faculty of Medicine and Health Sciences) at International University of Catalonia (UIC). She also has led several national and international research projects in iron-related diseases including Myelodysplastic Syndrome, Hereditary Hemochromatosis and Congenital Anaemias.


Santiago Pérez Montero

Co-founder of BG, expert in informatics.

Mr. Pérez is informatician working for more than 20 years in different industrial sectors with relevant job positions as team leader inside SEAT (car manufacturer from Volkswagen group in Spain). He also worked 3 years at the European Molecular Biology Laboratory (EMBL) at Heidelberg, Germany as scientific maintenance officer.



Pau Tomàs i Fernandez

Laboratory technician.

Pau Tomàs studied Biochemistry at the Autonomous University of Barcelona (UAB) and completed his studies with a master’s degree in Pharmacology, also at the UAB. During his university career, Pau developed essential technical and analytical skills in the fields of biochemistry and pharmacology. His master’s degree provided him with a deep understanding of pharmacological processes and an ability to address complex issues in the field of health and medicine. With a passion for research and laboratory work, Pau has stood out for his precision, attention to detail, and ability to work in a team. His academic and practical experience has allowed him to become familiar with a wide range of laboratory techniques and procedures, from sample handling to data analysis. Pau joined Bloodgenetics with the aim of applying his experience in clinical analysis. His commitment to scientific excellence and dedication to improving public health make him a valuable member of the team, capable of significantly contributing to the success of the company.


Natàlia Capdevila Pelejero

Regulatory Affairs and quality technician.

Natàlia Capdevila studied Biotechnology at the University of Vic. During her studies, Natàlia acquired deep knowledge in various areas of biotechnology, including laboratory techniques, molecular biology, and biotechnological processes. Her training provided her with a solid foundation in understanding fundamental scientific principles and practical applications in the biotechnology field. Natàlia has since developed her professional career in the field of quality and regulatory management at Bloodgenetics. She plays a crucial role in ensuring that the company’s products and processes comply with quality standards and regulations required by health authorities and regulatory bodies. Thanks to her commitment to excellence and attention to detail, Natàlia plays a fundamental role in the success of Bloodgenetics, ensuring that the company maintains the highest quality standards and complies with all relevant regulations in the development and commercialization of its products and services.


Mar Navarro Padilla


Mar Navarro studied Bioinformatics at Pompeu Fabra University (ESCI-UPF) and earned a master’s degree in Data Science from Radboud University in the Netherlands. During her academic training, Mar acquired specialized knowledge in the analysis of biological data and advanced bioinformatics techniques. Her master’s degree provided her with a solid foundation in statistics, programming, and machine learning, skills that are essential in the field of data science applied to biology and medicine. Mar joined Bloodgenetics with the aim of applying her expertise in bioinformatics and data science to advance research and the development of innovative and personalized therapies. Her passion for genomics and her ability to translate complex data into meaningful information make her an invaluable asset to the team, contributing to the company’s progress in seeking solutions to improve human health.



Vladimir Benes

Head of Genomics Core Facility at EMBL-Heidelberg, Germany, PhD in Biochemistry.

Dr. Vladimír Beneš is Head of GeneCore facility at the prestigious institute European Molecular Biology Laboratorium (EMBL) in Heidelberg, Germany.

He has been at EMBL since 1994 when he came as postdoc to Ansorge group in the Biochemical Instrumentation Unit.

In 2001 he was appointed to build EMBL Genomics Core Facility, a technology orientated service laboratory founded to assist researchers with functional genomics projects. This facility is currently utilizing mainly massively parallel sequencing & microarray technologies as well as qPCR. Among Vladimir’s tasks belong also assessment of new technologies and functional genomics applications, in particular their suitability for implementation in the environment of core facilities. He is also strongly involved in teaching of methods applied in this field.


David Beneitez

Medical doctor specialist in haematology at Hospital de la Vall d’Hebrón (Barcelona)

Dr. Beneitez is specialist in hematology and responsible for the Red Series Congenital Erythrology and Pathology Unit at the Vall de Hebrón University Hospital in Barcelona. Together with Dr. Albert Altés, he yearly organizes the eritropathology course of the Academy of Medical Sciences of Catalonia.

He is member of the HUVH Minority Diseases Commission, collaborates with the ORPHANET, ENERCA and CATGLOBIN networks as well as with ALHETA and TIF (hemoglobinopathies) patient associations.

He is also member of the National Group of Eritropathology, the Iberian Group of Ferropatology, the Spanish Society Hematology and Hemotherapy, as well as member of the Societat Catalana d’Hematologia i Hemoterapia.


Nathan Subramaniam

Professor in Biomedical Science and Molecular Medicine, PhD in Biomedical Science, Queensland University of Technology (QUT), Australia.

Prof. Dr. Nathan Subramaniam is Honorary Professor and Professor at the Faculty of Medicine and Biochemical Sciences at the University of Queensland and head of the Research Group on Liver Diseases and Iron Disorders at the Institute of Health and Biomedical Innovation (IHBI) since August 2016. PhD from Purdue University, W. Lafayette, Indiana, USA, 1990. Performed postdoctoral research stays at the University of California at Davis, USA and in Singapore. In 1999 he set up his own research group, the Membrane Transport Laboratory at the Queensland Medical Research Institute, Brisbane, Australia. His group is expert in hereditary hemochromatosis and in studies of liver injury and hepatic regulation of iron homeostasis. He has also developed new mass sequencing tools to examine the molecular basis of iron metabolism disorders, as well as, new in vitro and in vivo models to investigate hepatic damage and iron metabolism.


Inés Hernández Rodríguez

Co-founder and Medical doctor specialist in Haematology. PhD in medicine

Dr. Hernández has a doctoral degree in medicine. She is medical doctor specialized in Haematology working at the University Hospital Germans Trias I Pujol (HGTiP) as part of the Catalan Oncology Institute (ICO). She has more than 10 years of experience in diagnosis and clinical Haematology. She is responsible for the area of Erythropathology at the Haematology Service of the HGTIP and ICO.


Domenico Girelli

Medical doctor specialist in Internal Medicine, PhD in Experimental haematology, University of Verona, Italy

Prof. Dr. Domenico Girelli is an MD internist with a doctorate in experimental haematology and Professor of Internal Medicine at the Department of Medicine, University of Verona, Italy. His field of research focuses on Cardiovascular Genomics and Iron Metabolism. Since 2015 he has been in charge of the Reference Center for the Diagnosis and Therapy of Iron Metabolism Disorders at the Policlinico Hospital G.B. Rossi, Verona.


Albert Altés

Medical doctor specialist in Haematology at Althaia Foundation (Manresa, Spain), PhD. in Medicine.

Dr. Altés is haematologist, head of the Haematology Service at Althaia Foundation and professor of haematology at the International University of Catalonia.

He received his doctorate in medicine in the study of iron overload in hematopoietic transplantation. He is founder and president of the Spanish Association of Hemochromatosis. He has published over 100 international articles on haematology, especially on pharmacogenetics, iron overload and hemochromatosis. He yearly organizes the erythropathology course of the Academy of Medical Sciences of Catalonia.